Differential behavioural and biochemical effects on the central nervous system by cycloserine isomers.
D000818:Animals; D000928:Antidepressive Agents / Q000627:therapeutic use*; D001921:Brain / Q000201:enzymology*; D003109:Colonic Diseases, Functional / Q000188:drug therapy*; D003523:Cycloserine / Q000494:pharmacology*; D004569:Electroencephalography; D000882:Haplorhini; D006801:Humans; D008099:Liver / Q000201:enzymology*; D051379:Mice; D008995:Monoamine Oxidase / Q000378:metabolism*; D010433:Pentylenetetrazole / Q000633:toxicity; D011600:Psychopharmacology; D051381:Rats; D012110:Reserpine / Q000633:toxicity*; D012640:Seizures / Q000628:therapy*; D012701:Serotonin / Q000378:metabolism; D014149:Tranquilizing Agents / Q000627:therapeutic use*; D014363:Tryptamines / Q000378:metabolism / Q000633:toxicity; D014397:Tuberculosis, Pulmonary / Q000188:drug therapy*
D000928:Antidepressive Agents; D014149:Tranquilizing Agents; D014363:Tryptamines; D012701:Serotonin; D012110:Reserpine; D003523:Cycloserine; D008995:Monoamine Oxidase; D010433:Pentylenetetrazole